NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
Clinical Trials
10 trialsNCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT06214195 2024-01-19
START
Zhejiang Cancer Hospital
Phase 3 Recruiting
NCT05728632 2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3 Unknown
NCT03389724 2022-11-08
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT02236806 2022-02-01
SAFE
Azienda Ospedaliero-Universitaria Careggi
Phase 3 Unknown
NCT04030546 2019-12-18
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
Vilnius University
Phase 3 Unknown
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT00459771 2014-12-02
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
The Netherlands Cancer Institute
Phase 3 Completed
NCT00854568 2014-08-20
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Phase 3 Completed